Results 201 to 210 of about 37,178 (276)

Expression of cytochrome P450 2C9 (CYP2C9) in Escherichia coli and its functional characterization

, 2019
Boon Hooi Tan, Yan Pan, Uma Devi Palanisamy, Iekhsan Othman, Nafees Ahmed, Beow Chin Yap, Chin Eng Ong   +6 more
openalex   +1 more source

Extrapyramidal and anticholinergic reactions in an adolescent patient: a case for pharmacogenetic consideration. [PDF]

Biochem Med (Zagreb)
Žunić Išasegi I, Stefanović I, Okružnik Želalić M, Šimičević L, Ganoci L, Živković M, Begovac I, Božina N.   +7 more
europepmc   +1 more source

Positioning siponimod and the post-treatment gap: the unmet needs of SPMS patients in Italian real-world practice. [PDF]

Ther Adv Neurol Disord
Zanghì A, Borriello G, Foschi M, Bianco A, Signoriello E, Cellerino M, Di Filippo PS, Baldisseri F, Romano G, Cicia A, Lus G, Inglese M, Mirabella M, Avolio C, D'Amico E.   +14 more
europepmc   +1 more source

The influence of severe hepatic dysfunction on the metabolic capacity of the liver in children : composition and characterization of a liver tissue bank [PDF]

, 2011
Boussery, K, De Bock, L, De Paepe, Peter, Sokal, E, Stephenne, X, Van Bocxlaer, J, Van Winckel, Myriam   +6 more
core   +1 more source

Physcion inhibition of CYP2C9, 2D6 and 3A4 in human liver microsomes [PDF]

Lu Liu, Sen Sun, Xiaohua Li
openalex   +1 more source

The Genetic Polymorphisms of CYP2C9 and VKORC1 in the Saudi Population and Their Impact on Anticoagulant Management. [PDF]

Medicina (Kaunas)
Al Hamad M.
europepmc   +1 more source

CYP2C9, CYP3A and CYP2C19 metabolize Δ9-tetrahydrocannabinol to multiple metabolites but metabolism is affected by human liver fatty acid binding protein (FABP1)

King C. Yabut, Yue Winnie Wen, Keiann T. Simon, Nina Isoherranen   +3 more
openalex   +1 more source

The allele frequency of CYP2C9 and VKORC1 in the Southern Khorasan population

, 2017
Mohsen Naseri, FaribaEmadian Razavi, Asghar Zarban, Fatemeh Hajipoor   +3 more
openalex   +1 more source

An Overview of Endometriosis and Potential Pharmacogenetic Targets. [PDF]

Pharm Res
Pérez-Gómez N, Martínez-Zamora MÁ, Carmona F, Novalbos J, Abad-Santos F, Koller D, Saiz-Rodríguez M.   +6 more
europepmc   +1 more source

Exploring the roles of cytochrome P450 enzymes and their inhibitors in cancers and non-neoplastic human diseases. [PDF]

Arch Pharm Res
Lee H, Kwon YJ, Chun YJ.
europepmc   +1 more source